Real Voices, Real Rx Reform
The PBM Accountability Project members and partners are highlighting a shared concern: middlemen and vertically integrated insurers are driving up costs and creating real barriers to patient affordability and access. Watch new video testimonials and hear why meaningful reform targeting PBMs, group purchasing organizations (GPOs) and insurers cannot wait:
Emma Freer, Senior Health Policy Analyst, American Economic Liberties Project
How has vertical integration in the health insurance industry affected patient choice, medication access and drug pricing fairness?
Tell us more about the American Economic Liberties Project, and your Break Up Big Medicine Campaign.
George Huntley, Chief Executive Officer, The Diabetes Patient Advocacy Coalition
What impacts have you seen on patient choice, medication access and the fairness of drug pricing with the vertical integration of the health insurance industry?
What regulatory or legislative changes do you believe would most effectively address harmful PBM practices and reduce negative impacts from insurer-PBM vertical integration?
How do PBMs affect patient access to pharmacies and contribute to pharmacy closures?
Suzanna Masartis, CEO, Community Liver Alliance
How have PBM practices and lack of transparency affected patients’ ability to access and afford their prescribed medications?
Why is CLA interested in PBM reform and vertical integration of the health insurance industry?
Dr. Harry L. Gewanter, Board of Directors, Coalition of State Rheumatology Organizations
Why do CSRO and ATAP care about PBM reform and vertical integration of the health insurance industry?
What impacts have you seen on patient choice, medication access and the fairness of drug pricing with the vertical integration of the health insurance industry?
Anne Cassity, Senior Vice President, Government Affairs at National Community Pharmacists Association (NCPA)
What regulatory or legislative changes do you believe would most effectively address harmful PBM practices and reduce negative impacts from insurer-PBM vertical integration?
How are PBMs impacting independent pharmacies and the communities that rely on them for medical needs?
Sally Greenberg, CEO, National Consumers League
How have PBMs affected consumers’ ability to access and afford their prescriptions?
What should consumers should know about PBMs and how can they advocate for more transparency and fair Rx pricing?
How does consolidation and vertical integration within the health insurance industry impact consumers? How can we fix this?
T.J Woodard, Co-Owner Prescriptions to Geaux
What regulatory or legislative changes would most effectively address harmful PBM practices lower Rx costs?
How have PBM practices and lack of transparency affected patients’ ability to access and afford their prescribed medications?
How has vertical integration in the health insurance industry affected patient choice, medication access and drug pricing fairness?